Patent ID: 7348336

Claim:
A method for treating a patient experiencing at least one disorder involving an increased activity of I k B kinase, wherein the at least one disorder is allograft rejection, the method comprising administering to the patient an efficacious amount of at least one compound chosen from a compound of formula I a stereoisomeric form of a compound of formula I, and a physiologically tolerable salt of a compound of formula I, wherein B 6 , B 7 , B 6 and B 9 are ring atoms independently chosen from carbon atoms and nitrogen atoms and wherein B 6 , B 7 , B 8 and B 9 together are no more than two nitrogen atoms at the same time; where the substituents R 1 , R 2 , R 3 , R 4 and R 8 may be independently chosen from 1. hydrogen atom, 2. halogen, 3. —OH, 4. —CN, 5. sulfo, 6. —NO 2 , 7. —NH 2 , 8. alkoxy, 9. substituted amino, 10. —NH—C(O)—R 15 , wherein R 15 is a heterocycle having 5 to 7 ring atoms, an alkyl, an aryl, a substituted aryl or a substituted alkyl, 11. —COOH, 12. —O—R 10 , wherein R 10 is alkyl, substituted alkyl or aryl, 13. —C(O)—R 12 , wherein R 12 is alkyl, substituted alkyl or aryl, 14. —C(O)—O—R 12 , wherein R 12 is alkyl, substituted alkyl or aryl, 15. aryl, 16. —O-aryl, 17. substituted aryl, 18. —O-substituted aryl, 19. alkyl, 20. substituted alkyl, 21. —CF 3 and 22. —CF 2 —CF 3 , provided that at least one of R 1 , R 2 , R 3 , R 4 and R 8 is not a hydrogen atom, and provided that at least one of R 1 , R 3 , R 4 and R 8 is chosen from —NH—C(O)—R 15 , wherein R 15 is an aryl or a substituted aryl; R 5 is 1. hydrogen atom, 2. alkyl, 3. alkyl radical, substituted at one or more positions by one or more of the radicals, halogen, amino or hydroxyl, 4. —C(O)—R 9 or 5. —S(O) 2 —R 9 , in which R 9 is a) alkyl, b) alkyl radical, substituted at one or more positions by one or more of the radicals, halogen, amino or hydroxyl, c) aryl, d) aryl radical, substituted at one or more positions by one or more of the radicals, halogen, amino, or hydroxyl, e) —NH 2 , f) alkoxy or g) substituted amino, and R 6 and R 7 may be independently chosen from 1. hydrogen atom, 2. halogen, 3. —OH, 4. methyl, 5. —O—(C 1 -C 10 )-alkyl, wherein alkyl is unsubstituted or mono- to tri-substituted by substituents independently chosen from 5.1 aryl, 5.2 halogen, 5.3 —NO 2 , 5.4 sulfo, 5.5 —COOH, 5.6 —NH 2 , 5.7 —O—(C 1 -C 4 )-alkyl and 5.8 —OH, and 6. —N(R 13 ) 2 , wherein R 13 is independently of one another chosen from hydrogen atom, aryl, —C(O)—(C 1 -C 4 )-alkyl and substituted aryl or alkyl, wherein said —C(O)—(C 1 -C 4 )-alkyl is unsubstituted or mono- or tri-substituted independently of one another as defined under 5.1 to 5.8, or R 13 together with the nitrogen atom to which it is bonded form a heterocycle having 5 to 7 ring atoms.